分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Single-Cell Sequencing Analysis-Driven Nanomedicine Design for Mimicking Endogenous Immune Repair in Myocardial Infarction

Buayishamu Kutilike, Xueqi Lv, Yuqing Gong, Yi Dou, Xiangyun Zhang, Qiqi Liu, Junwen Su, Jin Wu, Helong Kang, Yingqi Miao, Baofa Sun, Xinglu Huang, Jie Zhuang

Journal:ACS Nano

IF:16

DOI:10.1021/acsnano.6c01251

PMID:41934404

Published:2026-04-04

research field:心血管研究免疫学单细胞基因组学再生医学纳米医学

Abstract

Mimicking endogenous immune cell responses holds great promise for repairing tissue damage in myocardial infarction (MI), yet challenges persist due to the heterogeneity, spatiotemporal dynamics, and diverse functions of macrophage subtypes during post-MI repair. Herein, we introduce a data-driven biomimetic strategy that leverages the sequential delivery of immune cell-mimicking nanoparticles to replicate the natural immune repair mechanisms. Using single-cell RNA sequencing, we analyzed the dynamic changes in immune cells during post-MI repair, revealing the distinct roles of macrophage subtypes in different stages of recovery. Building on these insights, we developed immune cell-mimicking nanoparticles and devised a sequential delivery strategy to emulate the temporal distribution of three macrophage subtypes (M2a, M2b, and M2c) throughout the MI repair process. Our results demonstrated that each macrophage subtype played a unique and time-dependent role in the repair process. Among various delivery strategies tested, the sequential delivery of M2a, M2b, and M2c nanoparticles emerged as the most effective approach for promoting MI recovery. This study not only provides an innovative framework for the design and application of immune cell-mimicking nanoparticles in MI treatment but also underscores the importance of replicating natural healing processes in nanomedicine development.

本文使用的Yeasen产品

购物车
客服
转染试用